Gary Roome
Family Medicine · Burton, MINPI 1376534396
Payments from drug & device makers
Across 103 payments — averaging $19.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$522
- Otsuka America Pharmaceutical, Inc.$296
- AbbVie$234
- AstraZeneca$148
- Amgen$110
- Novo Nordisk$104
- plus $639 from 19 others
What the payments were for
- Food & beverage$2,052100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 17 | $522 |
| Otsuka America Pharmaceutical, Inc. | 12 | $296 |
| AbbVie(2 entities) | 11 | $234 |
| AstraZeneca | 6 | $148 |
| Amgen | 6 | $110 |
| Novo Nordisk | 5 | $104 |
| Sunovion Pharmaceuticals Inc. | 15 | $100 |
| Johnson & Johnson | 4 | $66 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $63 |
| Exact Sciences | 2 | $55 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Merck | 2 | $34 |
| Pfizer | 2 | $31 |
| Lilly USA, LLC | 2 | $29 |
| Hologic Sales And Service, LLC | 1 | $25 |
| Avanir Pharmaceuticals, Inc. | 2 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $22 |
| Organon | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Eisai Inc. | 1 | $17 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AREXVY$235
How this compares
$2,052 in reported general payments places this provider in the 80th percentile of 3,945 family medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 169 | $169,506 |
| EliquisApixaban | 82 | $89,586 |
| JardianceEmpagliflozin | 23 | $32,480 |
| JanuviaSitagliptin Phosphate | 21 | $26,659 |
| XareltoRivaroxaban | 15 | $22,725 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 376 | $20,161 |
| SymbicortBudesonide/Formoterol Fumarate | 42 | $18,358 |
| EntrestoSacubitril/Valsartan | 15 | $17,781 |
| TradjentaLinagliptin | 21 | $15,812 |
| TrulicityDulaglutide | 14 | $15,326 |
| Ventolin HfaAlbuterol Sulfate | 156 | $12,035 |
| BrilintaTicagrelor | 18 | $11,660 |
| FarxigaDapagliflozin Propanediol | 14 | $10,298 |
| Atrovent HfaIpratropium Bromide | 17 | $8,903 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 88 | $8,857 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $522 | $169,506169 claims |
| PfizerEliquis | $31 | $89,58682 claims |
| AstraZenecaSymbicort, Brilinta, Farxiga | $148 | $40,31574 claims |
| MerckJanuvia | $34 | $26,65921 claims |
| Johnson & JohnsonXarelto | $66 | $22,72515 claims |
| Lilly USA, LLCTrulicity | $29 | $15,32614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Burton
- Kristina NikolakeasBurton$25K
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
- Loren ChudlerSouthfield$1.3M
- Solomon AmsterWhite Lake$981K
- Matt RosenbergJackson$559K
- Rhonda MejeurGrand Rapids$493K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.